Profilo
Isabelle de Cremoux is CEO & Managing Partner at Seventure Partners SA since 2011 and Chief Executive Officer & Managing Partner at Seventure Partners SA (Investment Management) since 2011.
Director roles are held at Enterome SA (since 2008), YSOPIA Biosciences SA (since 2015), Maat Pharma SA (Non-Independent Non-Executive Director since 2014), TargEDys SA, The Akkermansia Co., LiMM Therapeutics SA, Iome Bio SA, and Robertet SA (since 2023).
Managing Partner positions are held at Ms. de Cremoux SAS and Health for Life Management.
Former roles include Director-Business Development at Laboratoires Fournier SAS from 1998 to 2009, Director at MERISTEM Therapeutics SA, Vivostat A, Fluxome Sciences A, Biophytis SA, Polaris SA, and Nutrionix SA. Independent Director at Givaudan France Naturals SAS from 2015 to 2018.
Principal at Arthur Andersen LLP and Pfizer, Inc. Education includes undergraduate studies at École Centrale Paris.
Posizioni attive di Isabelle de Cremoux
| Società | Posizione | Inizio |
|---|---|---|
| MAAT PHARMA | Direttore/Membro del Consiglio | 01/01/2014 |
| ROBERTET | Direttore/Membro del Consiglio | 14/06/2023 |
Iome Bio SA
Iome Bio SA Pharmaceuticals: OtherHealth Technology Provides drug discovery services using microbiome based mechanisms | Direttore/Membro del Consiglio | - |
A-Mansia Biotech SA (Belgium)
A-Mansia Biotech SA (Belgium) Pharmaceuticals: OtherHealth Technology Produces probiotic and postbiotic supplements | Direttore/Membro del Consiglio | - |
Health for Life Management
Health for Life Management MiscellaneousMiscellaneous Operates as a holding company | Corporate Officer/Principal | - |
Isabelle de Cremoux SAS
Isabelle de Cremoux SAS Investment ManagersFinance Provides funds management services | Corporate Officer/Principal | - |
LiMM Therapeutics SA
LiMM Therapeutics SA Financial ConglomeratesFinance Functions as an investment holding company | Direttore/Membro del Consiglio | - |
TargEDys SA
TargEDys SA BiotechnologyHealth Technology Develops and manufactures nutritional solutions to control metabolic diseases | Direttore/Membro del Consiglio | - |
YSOPIA Biosciences SA
YSOPIA Biosciences SA BiotechnologyHealth Technology Develops therapeutic solutions for metabolic and cardiometabolic disorders | Direttore/Membro del Consiglio | 10/03/2015 |
| ░░░░░░░░░ ░░░░░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░░░ | ░░░░░░░░░░ |
Precedenti posizioni note di Isabelle de Cremoux
| Società | Posizione | Fine |
|---|---|---|
| ░░░░░░░ | ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░░░ ░░░ | ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
| ░░░░░░░ ░░░░ ░░░░░░░ ░░░░░ ░░░░░░░░░░░░ ░░░░░░░░░░░░░░ ░░░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
| ░░░░░░░░░░░░ ░░░░░░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Formazione di Isabelle de Cremoux
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 22 |
|---|---|
Robertet SA
Robertet SA Food: Specialty/CandyConsumer Non-Durables Produces and distributes aromatic products | Consumer Non-Durables |
Naturex SA
Naturex SA Chemicals: SpecialtyProcess Industries Manufactures essential oils | Process Industries |
Laboratoires Fournier SAS
Laboratoires Fournier SAS Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical preparations | Health Technology |
Arthur Andersen LLP
Arthur Andersen LLP Miscellaneous Commercial ServicesCommercial Services Provides accounting services | Commercial Services |
MERISTEM Therapeutics SA
MERISTEM Therapeutics SA BiotechnologyHealth Technology Specializes in research and development of therapeutic proteins using plant biotechnology | Health Technology |
Seventure Partners SA
Seventure Partners SA Investment ManagersFinance Seventure Partners invests in companies located in Israel, Asia and North America primarily in Europe. The firm targets companies operating in the fields of digital technologies and life sciences sectors. It provides financing for seed, early and growth stage capital requirements with an investment size of EUR 0.5 - 20 million. | Finance |
Pfizer, Inc. /Angers & Val-de-Reuil Pharmaceutical Operations
Pfizer, Inc. /Angers & Val-de-Reuil Pharmaceutical Operations Pharmaceuticals: MajorHealth Technology Specializes in pharmaceutical products | Health Technology |
École Centrale Paris
École Centrale Paris Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Vivostat A/S
Vivostat A/S Medical SpecialtiesHealth Technology Manufactures and distributes systems for on-site preparation & application of autologous concentrated fibrin and platelet enriched fibrin sealants | Health Technology |
Fluxome Sciences A/S
Fluxome Sciences A/S BiotechnologyHealth Technology Provides biotechnology services | Health Technology |
Biophytis SA
Biophytis SA Pharmaceuticals: OtherHealth Technology Develops and markets dietary supplements and ingredients for functional food based on tropical plants | Health Technology |
Polaris SA /FR/
Polaris SA /FR/ Food: Specialty/CandyConsumer Non-Durables Engages in production, development and formulation of polyunsaturated fatty acids | Consumer Non-Durables |
Enterome SA
Enterome SA Pharmaceuticals: MajorHealth Technology Develops immunomodulatory drugs for treatment of cancer | Health Technology |
Nutrionix SA
Nutrionix SA Pharmaceuticals: MajorHealth Technology Provides diet products | Health Technology |
YSOPIA Biosciences SA
YSOPIA Biosciences SA BiotechnologyHealth Technology Develops therapeutic solutions for metabolic and cardiometabolic disorders | Health Technology |
Maat Pharma SA
Maat Pharma SA Pharmaceuticals: MajorHealth Technology Operates as a clinical stage company which develops and commercializes patient-microbiome symbiosis to improve survival outcomes in oncology | Health Technology |
TargEDys SA
TargEDys SA BiotechnologyHealth Technology Develops and manufactures nutritional solutions to control metabolic diseases | Health Technology |
Isabelle de Cremoux SAS
Isabelle de Cremoux SAS Investment ManagersFinance Provides funds management services | Finance |
A-Mansia Biotech SA (Belgium)
A-Mansia Biotech SA (Belgium) Pharmaceuticals: OtherHealth Technology Produces probiotic and postbiotic supplements | Health Technology |
LiMM Therapeutics SA
LiMM Therapeutics SA Financial ConglomeratesFinance Functions as an investment holding company | Finance |
Health for Life Management
Health for Life Management MiscellaneousMiscellaneous Operates as a holding company | Miscellaneous |
Iome Bio SA
Iome Bio SA Pharmaceuticals: OtherHealth Technology Provides drug discovery services using microbiome based mechanisms | Health Technology |
















